Loading the session
Loading the session
Loading instrument
$465.24
+1.16%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 15:21 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Trailing P/E of 117.8 against a median of 38.3 across 3 peers named in its company record (range 34.6 to 78.6).
Quote feed P/E (price ÷ trailing 12-month EPS); peers as named in the company record · as of 4 Nov 2026
1 month: +4.5% (SPY −2.6%, XLV +9.9%). 3 months: +16.1% (SPY −2.2%, XLV +13.5%). 1 year: +33.1% (SPY +10.4%, XLV +27.4%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: WAT, SPY and XLV · as of 3 Nov 2026
Closed at $459.90 on 3 Nov 2026: 4.6% below the 52-week high of $482.28 (28 Oct 2026) and 62.6% above the low of $282.77 (13 Mar 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
3 Nov 2026 volume of 1.8M shares was 1.9× the average of the 30 sessions before it (923.6K), as the price rose 2.3%. SPY traded 0.8× its own average that session.
Daily volume against a 30-session baseline · as of 3 Nov 2026
The 3 Nov 2026 close of $459.90 was 6.5% above its 50-day average ($431.94) and 24.2% above its 200-day average ($370.15). It has closed above the 200-day for 112 sessions, since 27 May 2026. The 50-day average crossed above the 200-day on 1 Jul 2026, 87 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
Price return, split-adjusted
At the 3 Nov 2026 close
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
February 9, 2026
−13.94%July 14, 2025
−13.81%November 1, 2024
+19.84%